rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2012-1188rsp-1102Research ArticleСтатьиArticlesО НЕКОТОРЫХ ПОДХОДАХ К КОЛИЧЕСТВЕННОЙ ОЦЕНКЕ СНИЖЕНИЯ ПРОИЗВОДИТЕЛЬНОСТИ ТРУДА ПРИ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЯХSOME APPROACHES TO QUANTITATIVE EVALUATION OF REDUCED PRODUCTIVITY IN SUBJECTS WITH RHEUMATIC DISEASESKrichevskayaOlga ArkadyevnaKrichevskayaOlga Arkadyevna4101878@mail.ruVakulenkoO YuVakulenkoO Yu-GoryachevD VGoryachevD V-ЭрдесШ. Ф.ErdesSh F-201215102012505№5 (2012)9097Copyright © Krichevskaya O.A., Vakulenko O.Y., Goryachev D.V., Эрдес Ш.Ф., 20122012Krichevskaya O.A., Vakulenko O.Y., Goryachev D.V., Эрдес Ш.Ф.Krichevskaya O.A., Vakulenko O.Y., Goryachev D.V., Erdes S.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/1102References<div><p>Sokka T., Kautiainen H., Pincus T. et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthr Res Ther 2010; 12: R42.</p><p>Chung C.P., Sokka T., Arbogast P.G. et al. Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US. Ann Rheum Dis 2006; 65: 1653-7.</p><p>Рациональная фармакотерапия ревматических заболеваний. Под ред. В.А. Насоновой, Е.Л. Насонова. М.: Литтерра, 2003: 17—8.</p><p>Minier T., Pentek M., Brodszky V. et al. Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 2010; 49(10): 1920—8.</p><p>Aghdassi E., Zhang W., St-Pierre Y. et al. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol 2011; 38(4): 658—66.</p><p>Edwards N.L., Sundy J.S., Forsythe A. et al. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011; 14(1): 10—5.</p><p>Rohekar S., Pope J. Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 2010; 28(1): 35—40</p><p>Healey E.L., Haywood K.L., Jordan K.P. et al. Impact of ankylosing spondylitis on work in patients across the UK. Scand J Rheumatol 2011; 40(1): 34—40.</p><p>Geuskens G.A., Hazes J.M., Barendregt P.J. et al. Work and sick leave among patients with early inflammatory joint conditions. Arthr Rheum 2008; 59: 1458-66.</p><p>Merkesdal S., Ruof J., Schoffski O. et al. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthr Reum 2001; 44: 528-34.</p><p>Burton W., Morrison A., Maclean R., Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006; 56(1): 18—27.</p><p>Verstappen S.M.M., Bijlsma J.W., Verkleij H. et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthr Rheum 2004; 51: 488-97.</p><p>Wolfe F., Michaud K., Choi H.K., Williams R. Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 2005; 32(10): 1875—83.</p><p>Mau W., Listing J., Huscher D. et al. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32: 721-8.</p><p>Verstappen S.M.M., Watson K.D., Lunt M. et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2010; 49(8): 1570-7.</p><p>Verstappen S.M.M., Boonen A., Verkleij H. et al. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis 2005; 64: 1754-60.</p><p>Zhang W., Anis A.H. The economic burden of rheumatoid arthritis: beyond health care costs. Clin Rheumatol 2011; 30(Suppl. 1): S25- S32.</p><p>Davis K., Collins S.R., Doty M.M. et al. Health and productivity among U.S. workers. Issue Brief (Commonw Fund) 2005; 856: 1-10.</p><p>Goetzel R.Z., Long S.R., Ozminkowski R.J. et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004; 46(4): 398-412.</p><p>Mitchell R.J., Bates M.P.H. Measuring health-related productivity loss. Population Health Management 2011; 2(14): 93-8.</p><p>Berger A., Hartrick C., Edelsberg J. et al. Direct and indirect economic costs amond private-sector employees with osteoarthritis. J Occup Environ Med 2011, Oct 20 [Epub. ahead of print].</p><p>Mattke S., Balakrishnan A., Bergamo G. et al. A review of methods to measure health-related productivity loss. Am J Manag Care 2007; 13(4): 211-7.</p><p>Ter Wee M.M., Lems W.F., Usan H. et al. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 2011, Oct 13 [Epub. ahead of print].</p><p>Van Roijen L., Essink-Bot M.L., Koopmanschap M.A. et al. Labor and health status in economio evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996; 12: 405-15.</p><p>Boonen A., Brinkhuizen T., Landewe R. et al. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010; 69(6): 1123-8.</p><p>Gladman D.D., Bombardier C., Thorne C. et al. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. J Rheumatol 2011; 38(7): 1355-62.</p><p>Zhang W., Bansback N., Guh D. et al. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis. J Rheumatol 2008; 35(9): 1729—36.</p><p>Lerner D., Amick B.C. 3rd, Rogers W.H. et al. The Work Limitations Questionnaire. Med Care 2001; 38: 72-85.</p><p>Walker N., Michaud K., Wolfe F. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients. J Rheumatol 2005; 32(6): 1006-12.</p><p>Kessler R.C., Barber C., Beek A. et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med 2003; 45: 156-74.</p><p>Wang P.S., Beck A., Berglund P. et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 2003; 45(12): 1303—11.</p><p>Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmaeconomics 1993; 4(5): 353—65.</p><p>Zhang W., Gignac M.A., Beaton D. et al. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol 2010; 37(9): 1805—14.</p><p>Prasad M., Wahlqvist P., Shikiar R. et al. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22(4): 225-44.</p><p>www.reillyassociates.net</p><p>Reilly M.C., McBurney C.R., Bracco A. Work absenteeism in IBS: measuring days versus hours missed. Presented ISPOR 8th Annual European Congress, Nov 6—8, 2005, Florence, Italy.</p><p>Zhang W., Bansback N., Boonen A. et al. Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis. Arthr Res Ther 2010; 12: R177.</p><p>Khandker R., Pinheiro G., Kay S. et al. Moderate to severe rheumatoid arthritis is associated with significant work and activity impairment in Brazil: findings from an observational study. Arthr Rheum 2009; 60 (Abstr. suppl.): 1852.</p><p>Radner H., Smolen J., Aletaha D. Remission of rheumatoid arthritis: benefits from socioeconomic and quality of life perspectives. Arthr Rheum 2009; 60 (Abstr. suppl.): 1382.</p><p>www.ispor.org/research_study_digest/research_index.asp</p><p>www.clinicaltrials.gov/ct2/show/NCT01405326 REstore Working Ability in RheumatoiD Arthritis (REWARD)</p><p>DiBonaventura M., Gupta S., McDonald V. et al. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. BMC Musculoskelet Disord 2011; 12: 83.</p><p>Reilly M.C., Gooch K.L., Wong R.L. et al. Validity, reliability and responsiveness of the work productivity and activity impairment questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 2010; 49(4): 812-9.</p><p>Gooch K., Dougados M., van der Heijde D. et al. Relationship between spondyloarthropathies and impaired work productivity. Ann Rheum Dis 2009; 68(Suppl. 3): 356.</p><p>Maksymowych W.P., Gooch K.L., Wong R.L. et al. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol 2010; 37: 2.</p></div><br /><div><p>Sokka T., Kautiainen H., Pincus T. et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthr Res Ther 2010; 12: R42.</p><p>Chung C.P., Sokka T., Arbogast P.G. et al. Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US. Ann Rheum Dis 2006; 65: 1653-7.</p><p>Рациональная фармакотерапия ревматических заболеваний. Под ред. В.А. Насоновой, Е.Л. Насонова. М.: Литтерра, 2003: 17—8.</p><p>Minier T., Pentek M., Brodszky V. et al. Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 2010; 49(10): 1920—8.</p><p>Aghdassi E., Zhang W., St-Pierre Y. et al. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol 2011; 38(4): 658—66.</p><p>Edwards N.L., Sundy J.S., Forsythe A. et al. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ 2011; 14(1): 10—5.</p><p>Rohekar S., Pope J. Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 2010; 28(1): 35—40</p><p>Healey E.L., Haywood K.L., Jordan K.P. et al. Impact of ankylosing spondylitis on work in patients across the UK. Scand J Rheumatol 2011; 40(1): 34—40.</p><p>Geuskens G.A., Hazes J.M., Barendregt P.J. et al. Work and sick leave among patients with early inflammatory joint conditions. Arthr Rheum 2008; 59: 1458-66.</p><p>Merkesdal S., Ruof J., Schoffski O. et al. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthr Reum 2001; 44: 528-34.</p><p>Burton W., Morrison A., Maclean R., Ruderman E. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006; 56(1): 18—27.</p><p>Verstappen S.M.M., Bijlsma J.W., Verkleij H. et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthr Rheum 2004; 51: 488-97.</p><p>Wolfe F., Michaud K., Choi H.K., Williams R. Household income and earnings losses among 6,396 persons with rheumatoid arthritis. J Rheumatol 2005; 32(10): 1875—83.</p><p>Mau W., Listing J., Huscher D. et al. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32: 721-8.</p><p>Verstappen S.M.M., Watson K.D., Lunt M. et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2010; 49(8): 1570-7.</p><p>Verstappen S.M.M., Boonen A., Verkleij H. et al. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity. Ann Rheum Dis 2005; 64: 1754-60.</p><p>Zhang W., Anis A.H. The economic burden of rheumatoid arthritis: beyond health care costs. Clin Rheumatol 2011; 30(Suppl. 1): S25- S32.</p><p>Davis K., Collins S.R., Doty M.M. et al. Health and productivity among U.S. workers. Issue Brief (Commonw Fund) 2005; 856: 1-10.</p><p>Goetzel R.Z., Long S.R., Ozminkowski R.J. et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004; 46(4): 398-412.</p><p>Mitchell R.J., Bates M.P.H. Measuring health-related productivity loss. Population Health Management 2011; 2(14): 93-8.</p><p>Berger A., Hartrick C., Edelsberg J. et al. Direct and indirect economic costs amond private-sector employees with osteoarthritis. J Occup Environ Med 2011, Oct 20 [Epub. ahead of print].</p><p>Mattke S., Balakrishnan A., Bergamo G. et al. A review of methods to measure health-related productivity loss. Am J Manag Care 2007; 13(4): 211-7.</p><p>Ter Wee M.M., Lems W.F., Usan H. et al. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 2011, Oct 13 [Epub. ahead of print].</p><p>Van Roijen L., Essink-Bot M.L., Koopmanschap M.A. et al. Labor and health status in economio evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care 1996; 12: 405-15.</p><p>Boonen A., Brinkhuizen T., Landewe R. et al. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010; 69(6): 1123-8.</p><p>Gladman D.D., Bombardier C., Thorne C. et al. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. J Rheumatol 2011; 38(7): 1355-62.</p><p>Zhang W., Bansback N., Guh D. et al. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis. J Rheumatol 2008; 35(9): 1729—36.</p><p>Lerner D., Amick B.C. 3rd, Rogers W.H. et al. The Work Limitations Questionnaire. Med Care 2001; 38: 72-85.</p><p>Walker N., Michaud K., Wolfe F. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients. J Rheumatol 2005; 32(6): 1006-12.</p><p>Kessler R.C., Barber C., Beek A. et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med 2003; 45: 156-74.</p><p>Wang P.S., Beck A., Berglund P. et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med 2003; 45(12): 1303—11.</p><p>Reilly M.C., Zbrozek A.S., Dukes E.M. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmaeconomics 1993; 4(5): 353—65.</p><p>Zhang W., Gignac M.A., Beaton D. et al. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol 2010; 37(9): 1805—14.</p><p>Prasad M., Wahlqvist P., Shikiar R. et al. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22(4): 225-44.</p><p>www.reillyassociates.net</p><p>Reilly M.C., McBurney C.R., Bracco A. Work absenteeism in IBS: measuring days versus hours missed. Presented ISPOR 8th Annual European Congress, Nov 6—8, 2005, Florence, Italy.</p><p>Zhang W., Bansback N., Boonen A. et al. Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis. Arthr Res Ther 2010; 12: R177.</p><p>Khandker R., Pinheiro G., Kay S. et al. Moderate to severe rheumatoid arthritis is associated with significant work and activity impairment in Brazil: findings from an observational study. Arthr Rheum 2009; 60 (Abstr. suppl.): 1852.</p><p>Radner H., Smolen J., Aletaha D. Remission of rheumatoid arthritis: benefits from socioeconomic and quality of life perspectives. Arthr Rheum 2009; 60 (Abstr. suppl.): 1382.</p><p>www.ispor.org/research_study_digest/research_index.asp</p><p>www.clinicaltrials.gov/ct2/show/NCT01405326 REstore Working Ability in RheumatoiD Arthritis (REWARD)</p><p>DiBonaventura M., Gupta S., McDonald V. et al. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. BMC Musculoskelet Disord 2011; 12: 83.</p><p>Reilly M.C., Gooch K.L., Wong R.L. et al. Validity, reliability and responsiveness of the work productivity and activity impairment questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 2010; 49(4): 812-9.</p><p>Gooch K., Dougados M., van der Heijde D. et al. Relationship between spondyloarthropathies and impaired work productivity. Ann Rheum Dis 2009; 68(Suppl. 3): 356.</p><p>Maksymowych W.P., Gooch K.L., Wong R.L. et al. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol 2010; 37: 2.</p></div><br />
The authors declare that there are no conflicts of interest present.